These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2645844)

  • 21. Beyond the lab in biotech. With so many drugs in trial, new jobs are opening up.
    Carmichael M
    Newsweek; 2002 Sep; 140(13):53. PubMed ID: 12375414
    [No Abstract]   [Full Text] [Related]  

  • 22. A critical tipping point.
    Zuckerman MB
    US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366
    [No Abstract]   [Full Text] [Related]  

  • 23. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 24. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA
    Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospects for reform of the IND/NDA processes: Part I.
    Romansky MA
    J Clin Psychopharmacol; 1982 Oct; 2(5):358-61. PubMed ID: 6752215
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug safety. Gaps in the safety net.
    Couzin J
    Science; 2005 Jan; 307(5707):196-8. PubMed ID: 15653480
    [No Abstract]   [Full Text] [Related]  

  • 27. US company's gene therapy trial is first to bypass RAC for approval.
    Anderson C
    Nature; 1992 Jun; 357(6380):615. PubMed ID: 1614498
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotech's next big blowup?
    Stires D
    Fortune; 2002 Mar; 145(6):154. PubMed ID: 11913033
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug review, approval process changing.
    Goldsmith MF
    JAMA; 1985 Oct; 254(16):2221, 2227. PubMed ID: 4046147
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA to revise drug review process.
    Welsh JS
    Am Pharm; 1980 Jan; NS20(1):45. PubMed ID: 7369119
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence used for approval of new drugs.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From laboratory to medicine cabinet.
    Caring; 1992 Nov; 11(11):16-20. PubMed ID: 10121248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotechnology and patent term extension issues.
    Raines L
    Food Drug Law J; 1999; 54(2):237-40. PubMed ID: 11758579
    [No Abstract]   [Full Text] [Related]  

  • 37. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J
    Drug Discov Today; 2004 Jul; 9(13):548-50. PubMed ID: 15203087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug Administration.
    Feinsod M; Chambers WA
    Ophthalmology; 2004 Oct; 111(10):1801-6. PubMed ID: 15465539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ODAC Chronicles: Part 3. The FDA's philosophy and process for cancer drug evaluation and approval.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):1-5. PubMed ID: 15757431
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent developments help the defense of drug companies in 10b-5 cases.
    Salpeter AN; Hutchins H
    Food Drug Law J; 1996; 51(3):345-53. PubMed ID: 11797711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.